SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001171843-17-003576
Filing Date
2017-06-09
Accepted
2017-06-09 16:36:49
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-3 fs3_060917.htm S-3 388753
2 EXHIBIT 4.2 exh_42.htm EX-4.2 353681
3 EXHIBIT 4.4 exh_44.htm EX-4.4 132950
4 EXHIBIT 4.5 exh_45.htm EX-4.5 135006
5 EXHIBIT 4.6 exh_46.htm EX-4.6 117216
6 EXHIBIT 5.1 exh_51.htm EX-5.1 25158
7 EXHIBIT 23.1 exh_231.htm EX-23.1 2699
8 EXHIBIT 23.2 exh_232.htm EX-23.2 1843
9 GRAPHIC logo.jpg GRAPHIC 47124
10 GRAPHIC cooley.jpg GRAPHIC 32744
  Complete submission text file 0001171843-17-003576.txt   1268134
Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-218641 | Film No.: 17903398
SIC: 2834 Pharmaceutical Preparations